Bristol-Myers Squibb Company (BMY) “On a long-term technical basis, the stock (BMY) is trading below its 200-day moving average which generally implies it is in a negative trend.

The stock has support at 58.14 and 54.07. If the stock breaks down through support at 58.14 then it will probably continue lower to 54.07. The stock has resistance at 60.45 and at 64.27. If the stock breaks up through resistance at 60.45 then it will probably continue higher to 64.27. The 200-day moving average is at 60.50. This will also act as resistance. However, the stock has broken out of its long-term downtrend according to the fibonacci fan, which is significant. If the stock can form new support above 58.14 look for a rally to previous highs. The stock is neutral according to the Stochastic Indicator (56.98).”

Bristol-Myers Squibb Company (BMY) “On a long-term technical basis, the stock (BMY) is trading below its 200-day moving average which generally implies it is in a negative trend.

The stock has support at 54.07 and 47.25. If the stock breaks down through support at 54.07 then it will probably continue lower to 47.25. The stock has resistance at 58.78 and 62.17. If the stock breaks up through resistance at 58.78 then it will probably continue higher to 62.17. The 200-day moving average is at 58.78. This will also act as resistance. The stock’s long-term uptrend has changed into a sideways or downtrend. In this case, the stock will either go sideways for a while or sell-off back to where it started prior to the latest big upmove. This is a risky time to buy the stock, so be careful. Wait for the trend to change to bullish before entering. Use caution during times like these, as the stock will be more volatile. Confirm with the TMTI Indicator, Short-Term and Immediate Outlook for help entering. The stock is neutral according to the Stochastic Indicator (42.41).”

Bristol-Myers Squibb Company (BMY) “On a long-term technical basis, the stock (BMY) is trading below its 200-day moving average which generally implies it is in a negative trend.

The stock has support at 45.76 and 40.06. If the stock breaks down through support at 45.76 then it will probably continue lower to 40.06. The stock has resistance at 58.55 and 62.17. If the stock breaks up through resistance at 58.55 then it will probably continue higher to 62.17. The 200-day moving average is at 58.55. This will also act as resistance. The stock’s long-term uptrend has changed into a sideways or downtrend. In this case, the stock will either go sideways for a while or sell-off back to where it started prior to the latest big upmove. This is a risky time to buy the stock, so be careful. Wait for the trend to change to bullish before entering. Use caution during times like these, as the stock will be more volatile. Confirm with the TMTI Indicator, Short-Term and Immediate Outlook for help entering. The stock is slightly oversold according to the Stochastic Indicator (25.07).”

Bristol-Myers Squibb Company (BMY) “On a long-term technical basis, the stock (BMY) is trading above its 200-day moving average which implies it is in a positive trend. However, the stock has recently broken through an important trendline at 68.61 suggesting the next support level is at 63.62. This weakness suggests the long-term trend is turning neutral.

The stock has support at 63.62 and 59.68. If the stock breaks down through support at 63.62 then it will probably continue lower to 59.68. The stock will meet resistance at 64.75 and 68.34. If the stock breaks up through resistance at 64.75 then it will probably continue higher to 68.34. The 200-day moving average is at 57.04. This will also act as support. The stock is extremely overbought according to the Stochastic Indicator (76.32).”

Bristol-Myers Squibb Company (BMY) “On a long-term technical basis, the stock (BMY) is trading above its 200-day moving average which implies it is in a positive trend.

The stock has support at 64.75 and 60.66. If the stock breaks down through support at 64.75 then it will probably continue lower to 60.66. The stock will meet resistance at 67.00 and 72.84. If the stock breaks up through resistance at 67.00 then it will probably continue higher to 72.84. The 200-day moving average is at 50.94. This will also act as support. The stock is extremely overbought according to the Stochastic Indicator (78.01).”

Bristol-Myers Squibb Company (BMY) “On a long-term technical basis, the stock (BMY) is trading above its 200-day moving average which implies it is in a positive trend.

The stock has support at 57.37 and 54.09. If the stock breaks down through support at 57.37 then it will probably continue lower to 54.09. The stock will meet resistance at 58.46 and 66.57. If the stock breaks up through resistance at 58.46 then it will probably continue higher to 66.57. The 200-day moving average is at 49.04. This will also act as support. The stock is neutral according to the Stochastic Indicator (43.04).”

Bristol-Myers Squibb Company (BMY) “On a long-term technical basis, the stock (BMY) is trading above its 200-day moving average which implies it is in a positive trend.

The stock has support at 57.37 and 54.09. If the stock breaks down through support at 57.37 then it will probably continue lower to 54.09. The stock will meet resistance at 58.46 and 66.57. If the stock breaks up through resistance at 58.46 then it will probably continue higher to 66.57. The 200-day moving average is at 49.04. This will also act as support. The stock is neutral according to the Stochastic Indicator (43.04).”